Completed
A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies
NCT03922204
- Conditions
- Advanced Cancer, B-cell Lymphoma, Adult, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Moores Cancer Centre La Jolla, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- University Hospital Antwerp Antwerp, Edegem, Belgium